CytomX Therapeutics (CTMX) Other Non-Current Liabilities (2014 - 2026)
CytomX Therapeutics' Other Non-Current Liabilities was $4.47 million in Q2 2026, up 5.4% from $4.24 million a year earlier and up 1.4% from the prior quarter.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends
At the end of FY2025, Other Non-Current Liabilities at CytomX Therapeutics came in at $4.35 million, up 5.8% from FY2024.
- In earlier years, Other Non-Current Liabilities was $4.12 million in FY2024 (+5.7%) and $3.89 million in FY2023.
- The Q2 2026 figure marks the highest quarterly Other Non-Current Liabilities in data going back to Q4 2014.
- Compared with a year earlier, Other Non-Current Liabilities has increased for eight straight quarters, with growth averaging 11.0% over the last eight quarters.
- Across the past five years, year-over-year growth in Other Non-Current Liabilities ran from 5.4% in Q2 2026 to 47.0% in Q3 2024.
- Per Business Quant data, CTMX's Other Non-Current Liabilities in the three quarters before Q2 2026 was $4.41 million (Q1 2026), $4.35 million (Q4 2025) and $4.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | CytomX Therapeutics | 592.69 Mn | -364.98 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.47 Mn |
| Mar 31, 2026 | 4.41 Mn |
| Dec 31, 2025 | 4.35 Mn |
| Sep 30, 2025 | 4.30 Mn |
| Jun 30, 2025 | 4.24 Mn |
| Mar 31, 2025 | 4.18 Mn |
| Dec 31, 2024 | 4.12 Mn |
| Sep 30, 2024 | 4.05 Mn |
| Jun 30, 2024 | 3.99 Mn |
| Mar 31, 2024 | 3.94 Mn |
| Dec 31, 2023 | 3.89 Mn |
| Sep 30, 2023 | 2.76 Mn |
| Jun 30, 2023 | 216,000.00 |
| Dec 31, 2019 | 850,000.00 |
| Sep 30, 2019 | 963,000.00 |
| Jun 30, 2019 | 963,000.00 |
| Mar 31, 2019 | 963,000.00 |
| Dec 31, 2018 | 3.05 Mn |
| Sep 30, 2018 | 2.43 Mn |
| Jun 30, 2018 | 2.28 Mn |
API Access
CytomX Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();